Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02847702 · ClinicalTrials.gov registry record · Phase 2
A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee
A Phase 2 study, sponsored by Purdue Pharma.
- Terminated
- Registry status
- Phase 2
- Development phase
- 75
- Enrollment target
NCT02847702: Clinical Trial Phase 2 study, sponsored by Purdue Pharma.
NCT02847702 is a Phase 2 study that was terminated before completion, run by Purdue Pharma. The registered enrollment target is 75 participants, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02847702, a Phase 2 study, was terminated before completion, sponsored by Purdue Pharma.
- TERMINATED
- Registry status
- Phase 2
- Development phase
- 75 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the analgesic efficacy, safety, and tolerability of VM902A twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.
Interventions
- DRUG Placebo
- DRUG VM902A 200-mg Capsules
- DRUG VM902A 400-mg Capsules
- DRUG Naproxen 500-mg Capsules
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2016-08 |
| Est. Completion | 2016-11-22 |
| Phase | Phase 2 |
Why NCT02847702 stopped before completion
NCT02847702 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 75 participants, a relatively small participant target, below the 133-participant average among 30,622 other Phase 2 trials with a reported enrollment target (44% lower).
The record links to 0 conditions, and to 4 interventions - of which Placebo is the first listed.
NCT02847702 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02847702 about?
NCT02847702 is a clinical study titled "A Study to Evaluate the Analgesic Efficacy and Safety of VM902A in Subjects With Osteoarthritis (OA) of the Knee". The purpose of this study is to evaluate the analgesic efficacy, safety, and tolerability of VM902A twice daily compared to placebo in subjects with moderate to severe chronic pain due to OA of the knee.
What is the current status of trial NCT02847702?
This trial is currently terminated. It is a Phase 2 study. The enrollment target is 75 participants. The study started on 2016-08. Estimated completion is 2016-11-22.
What interventions are being tested in trial NCT02847702?
The interventions under investigation include: Placebo (DRUG), VM902A 200-mg Capsules (DRUG), VM902A 400-mg Capsules (DRUG), Naproxen 500-mg Capsules (DRUG).
Who is sponsoring clinical trial NCT02847702?
This trial is sponsored by Purdue Pharma, which has 54 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02847702's enrollment target sits among peer trials
75 900th of 2000 higher than 1,081 of 2,000 other Phase 2 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 2 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia